INSIGHTS ON CLINICAL TRIAL DESIGN
-
![peptides-preclinical-develop-GettyImages-2264393871]( "Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us")
Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells UsBenchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.
-
![GettyImages-1214111358 Team Of Professionals Working Together On Computer]( "Decentralized Clinical Trials: FDA Guidance Analyzed")
Decentralized Clinical Trials: FDA Guidance AnalyzedExplore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
![GettyImages-2210195887-tablet-phone-recruitment]( "How To Reduce Eligibility Risk And Prevent Protocol Deviations")
How To Reduce Eligibility Risk And Prevent Protocol DeviationsEliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
![eye drops-GettyImages-1406386094]( "Critical Imaging Risks In GLP-1 And Neurology Studies")
Critical Imaging Risks In GLP-1 And Neurology StudiesAs imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.
-
Why Is Clinical Trial Patient Travel So Important?4/28/2025
Removing travel barriers in clinical trials ensures broader access, diverse participation and stronger results, benefiting both patients and researchers alike.
-
ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials9/18/2025
The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.
-
Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design1/28/2026
Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.
-
Unlocking Recruitment Potential In Trial-Naïve Sites4/17/2025
Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.
-
Ophthalmology Assessments Made Simple: A Guide For Clinical Trials1/29/2025
Explore the importance and requirements of ophthalmology assessments as well as the key challenges that complicate their implementation at clinical sites.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1132766141 patient recruitment]( "A New Blueprint For Transforming Feasibility And Recruitment")
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
![Kidneys]( "Turnkey Solutions For Your Renal And Hepatic Impairment Studies")
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
![GettyImages-1141567619 doctor patient]( "First In Human (FIH) Fact Sheet")
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
-
![patient recruitment iStock-1299220556]( "Introducing Citeline PatientMatch: Precision Patient Recruitment")
The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.
-
![Diversity-iStock-1313246059]( "Enable Greater Diversity In Clinical Trials")
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.
